PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.

All new Pfizer and Moderna vaccines target the Omicron variant KP.2 strain of SARS-CoV-2, the virus that causes COVID. While the Pfizer and Moderna vaccines are mRNA-based, the Novavax vaccine is ...

Another COVID-19 variant is on the rise this fall, hot on the heels of a massive summer surge of the virus. The variant, ...

Today, Benzinga 's options scanner spotted 26 uncommon options trades for BioNTech. This isn't normal. The overall sentiment ...

Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

The U.S. Food and Drug Administration recently approved new versions of COVID vaccines ... circulating variants. The vaccines manufactured by ModernaTX Inc. and Pfizer Inc. now include a component ...

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...